United States · Who invested in Neurana?
Neurana's investors include Longitude Capital, H.I.G. BioHealth, MagnaSci and Sofinnova Ventures/ New Leaf.
United States · Series A startup
Who invested in Neurana
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2018, from 2 sources
- Latest round
- Series A, $60MMay 2018
- Investors
- 4
The rounds
- May 2018Series A$60M
Longitude Capital- H.I.G. BioHealth
- MagnaSci
- Sofinnova Ventures/ New Leaf
Reported by FinSMEs and 1 otherSEC filing: $3.8M sold, first sale Dec 2013
Everyone who backed them
H.I.G. BioHealthVC firm1round
MagnaScino record of our own yet1round
Sofinnova Ventures/ New Leafno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Neurana
How much has Neurana raised?
Neurana has raised $60M across 1 round since 2018.
When did Neurana last raise?
Neurana's most recent round was a Series A of $60M in May 2018.
What was Neurana's biggest round?
Its most recent round, $60M in May 2018, is also its largest on record.
Who backed Neurana first?
Neurana's first round on record, in May 2018, was backed by Longitude Capital, H.I.G. BioHealth and MagnaSci and 1 others.
What stage is Neurana at?
Neurana's latest named round is a Series A, in May 2018.
Where is Neurana based?
Neurana is based in the United States.
Companies like Neurana
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.